6-10 October 2024 • MARRAKESH / MOROCCO




This document contains information for authors preparing submissions to MICCAI 2024, and should be read in conjunction with the MICCAI review process document.

1. Call for Papers

MICCAI welcomes both methodological works and application studies including works focusing on translation.

Methodological works should represent highly innovative and ground-breaking methods, technologies, or systems, in the areas of interest to the MICCAI Society. These manuscripts need to demonstrate clear innovations and contributions over the state-of-the-art methodologies. The methodology evaluation and performance assessment can be potentially limited to proof of concepts or small-size validation studies. Authors and reviewers are encouraged to consider, argue, and justify whether a particular paper falls in this category.

Application studies should demonstrate the impact or clinical value of one or more existing techniques, or to adapt/adopt state-of-the-art methods to a new problem or context. These include performance evaluations on large datasets or in-human feasibility studies that rigorously and reproducibly demonstrate clinical relevance/viability in clinical practice or research settings. These studies will be assessed by the appropriateness of evaluation design, the soundness of their conclusions, and the existence of prior similar studies.

Topics of interest for MICCAI include, but are not limited to:

  • New methods in medical image computing
  • New methods in computer-assisted interventions
  • Imaging-related clinical studies
  • Clinical implementation and monitoring of imaging solutions
  • Integration of imaging and non-imaging data
  • Population imaging informatics
  • Image formation and reconstruction
  • Image-based personalised medicine
  • Surgical data science
  • Image-guided robotic surgery
  • Foundation models in medical imaging
  • Generalisable machine learning in medical imaging
  • Algorithmic fairness in medical imaging
  • Human-centred AI in medical imaging
  • Federated learning in medical imaging
  • Trustworthy AI in medical imaging
  • Accessible medical imaging solutions
  • Point-of-care imaging solutions
  • Image synthesis and augmentation for diverse populations
  • Teleradiology applications
  • Biomedical image computing for neglected diseases
  • Imaging solutions for vulnerable and under-represented populations

Clinical Translation session - This edition of the conference will again emphasize the progress of MICCAI research from theory to practice by featuring a clinical translation session reflecting the real-world impact of the field in clinical workflows and clinical evaluations. There will be an opportunity to showcase papers in a dedicated session on clinical translation. The philosophy of this dedicated session is to keep a high standard for methodology development while enabling a strong focus on the clinical application, and providing insights into clinical challenges that need to be introduced to the MICCAI community. Please select "Clinical Translation” category on your paper submission form.

*New in 2024* MICCAI for Health Equity session We are delighted to announce a new session at MICCAI entitled "MICCAI for Health Equity". This special session will highlight new MICCAI approaches that enhance access to healthcare and improve health outcomes for all populations worldwide, across diverse geographical, social, economic, and demographic determinants. To celebrate the first MICCAI in Africa, the 2024 edition of "MICCAI for Health Equity” will focus on geographical health equity and global health challenges. Hence, we welcome submissions that contribute new methods and applications that are attuned to diverse healthcare settings, in terms of data, infrastructure, resources, and costs, especially to address challenges in limited-resource settings. Ultimately, this session will showcase how innovation in MICCAI can bridge healthcare gaps and offer affordable and high-quality care to under-served populations worldwide. Please select "Health equity” category on your paper submission form.

To promote equality and diversity, the MICCAI organizers encourage submissions from female researchers and other underrepresented groups.

2. Submission Deadlines

The submission process will comprise two phases:

  • You will register your intention-to-submit by 23:59, Pacific Time, 22nd February 2024. This registration will require only the submission of the title, a complete author list, a complete list of domain conflicts, paper subject areas, and an abstract of the manuscript. You will NOT be able to submit your full manuscript without registering an intention-to-submit. Submissions can be edited until the deadline and the full paper is not required before the full manuscript submission deadline below.
  • At least one co-author of the paper must review for MICCAI 2024. Authors will be asked to provide the name and email address of the co-author who will participate as a reviewer. This co-author must complete the reviewer signup form before the intention-to-submit deadline (22nd February 2024). Note that student reviewers are to be at least enrolled at a Ph.D. level.
  • The full manuscript submission deadline will be 23:59, Pacific Time, 7th March 2024. There will be no extension.
  • Upload of supplementary material will be due at the time of submission until 23:59 Pacific Time, March 7th, 2024.

Please check the conference timeline on the website for further details on the review schedule. Late submissions will not be accepted.

You should submit using the Conference Management Toolkit (CMT) website. For both phases of the submission process, please see the CMT instructions for authors page for detailed instructions on how to register your intention-to-submit and how to navigate the CMT submission site. The paper submission system will open on 15th January 2024.

3. Manuscript Preparation and Submission

Listed below are several important requirements for preparing and submitting a manuscript to MICCAI 2024. Failure to abide by the following requirements when preparing your manuscripts may result in desk rejection of the manuscript:

  • Manuscript template: Papers must be submitted electronically in searchable pdf format following the guidelines for authors and LaTeX and MS Word templates available at Lecture Notes in Computer Science. Manuscripts should be up to 8-pages (text, figures and tables) plus up to 2 pages of references. No modifications to the templates are permitted. Non-compliance with the manuscript format, including paper length, will lead to automatic desk rejection.
  • Anonymization: The MICCAI Conference review process is double-blind, i.e. the names of the authors, reviewers, and area chairs are not revealed to each other. Papers must thus be properly anonymized before submission and breach of anonymization will lead to automatic desk rejection.
  • Disclose domain conflicts: To avoid conflict of interest among the authors, reviewers, and Area Chairs, all co-author information and a complete and accurate list of domain conflicts must be entered in the submission form by the submission deadline. For the same reason (to avoid conflict of interest during the review process), the author list must be complete at submission time, and cannot be modified after submission except in rare cases when such need can be justified and approved by the Program Chairs. It is unacceptable to retroactively include anyone as a co-author who has been directly or indirectly involved with the manuscript at any stage of the decision process either as a reviewer, Area Chair, or as part of the organizing committee.
  • Data use declaration and acknowledgment: Authors must declare the data origin, data license, and (when appropriate) ethics application number for any public or private data used in the preparation of the paper. The paper must include the co-authors, paper citations, and/or acknowledgments as required by any public or private data used in the preparation of the paper. The data use declaration and acknowledgment must be properly anonymized for the double-blind review process. The data use declaration does not have to be a dedicated section in the paper, and the required information can be provided anywhere in the main text (for example, as part of the description of the experimental setup).
  • Reviewing Responsibility: At least one co-author of your paper must review for MICCAI 2024. Note that student reviewers are to be at least enrolled at a Ph.D. level. You will be asked to submit the name and email address of a qualified co-author who will review. This co-author must complete the reviewer signup form before the intention-to-submit deadline.
  • Attendance responsibilities: All accepted MICCAI'24 papers must be presented in-person by an author registered for physical, in-person participation in the conference. This is crucial as the physical conference facilities do not support virtual participation or presentation. In particular, lack of travel funding or not wanting to travel cannot waive the requirement to present physically, in-person at the conference. In case of an emergency preventing physical participation, authors will need to contact the MICCAI program committee for a waiver. At the time of paper acceptance, we will notify authors with respect to obtaining the necessary invitation letter for visa applications to help expedite this process. First authors can present multiple papers with a single registration only if they are first authors on all papers.

    To support the physical presentation by authors from low- or middle-income countries, travel and participation grants will be made available to provide financial support for students and early-career scientists, including those from diverse and underserved backgrounds. Application details will become available shortly.

For more information on how to avoid format, anonymity, plagiarism, self-plagiarism, and other violations when preparing for your manuscripts, you are encouraged to read Submitting to MICCAI: Avoiding Desk Rejection by the MICCAI submission platform manager.

4. Review Process

MICCAI submissions will be evaluated by on average three external reviewers and 2-3 Area Chairs for potential inclusion in the scientific program of MICCAI. The MICCAI 20204 Program Committee has made some substantial changes to previous years. Details of the MICCAI 2024 review process here. Below are some important elements to assist authors with a smooth submission and review process.

Primary and Secondary Areas: Each paper must be submitted with Primary and Secondary areas selected from the CMT system. Authors also must identify to which stream the paper belongs, i.e., either MIC, CAI, MICCAI, Clinical Translation, or MICCAI for Health Equity. These areas, the stream, and the paper itself, will be used to generate suggested reviewers and Area Chair assignments using the automated Toronto Paper Matching System paper matching system embedded in the CMT system (see Stages 6 and 7 in MICCAI Review Process).

Statement of Novelty/Impact: This statement, of up to 500 characters in length, should provide the main argument for the inclusion of the paper in the conference. It should clarify whether the main significance of the contribution is in the novelty of the proposed methodology or the scientific/clinical impact of the conclusions or results. Note that this statement will be visible to reviewers and area chairs and should not identify the authors or their institutions.

Toronto Paper Matching System: By submitting a paper to MICCAI, the authors agree to the review process and understand that papers are processed by the Toronto Paper Matching System to match each manuscript to the best possible Area Chairs and reviewers.

Double-blind Review: To respect the double-blind review process of MICCAI, authors should not provide information that may identify them in the acknowledgments (e.g., co-workers and grant IDs), citations, or links to websites that may identify any of the authors. If you need to cite a different paper of yours that is being submitted concurrently to MICCAI, you should (1) cite these papers preserving anonymity, (2) argue in the body of your paper why your MICCAI paper is non-trivially different from those concurrent submissions, and (3) include anonymized versions of those papers in the supplementary material.

Publication of reviews: By submitting a paper to MICCAI, the authors agree to the review process and understand that, if their paper is accepted for publication, the reviews of their paper will be published as well, including potentially negative comments.

arXiv/BioRxiv: We realize that with the increase in popularity of publishing technical reports and arXiv papers (or other type of preprints), sometimes the authors of a paper may be known to the reviewer. Reviewers are strongly discouraged to search arXiv for submissions they are responsible to review. Even if they come across this information accidentally, they are discouraged to use the information in formulating their review.

arXiv papers are not considered prior work since they have not been peer-reviewed. Therefore, citations to those papers are not required and reviewers are asked to not penalize a paper that fails to cite an arXiv submission.

Dual/Double Submissions: All MICCAI 2024 submissions must be original and cannot already be published or considered for publication elsewhere (with the explicit exception of arXiv.org as a form of prepublication of MICCAI contributions).

By submitting a manuscript to MICCAI, authors acknowledge that their work has not been previously published, has not been accepted for publication, and is not under review for publication in substantially similar form in any peer-reviewed venue including journal, conference, and workshop. Furthermore, no paper substantially similar in content is allowed to have been or to be submitted to any other conference, workshop, or journal during the review period (March 7, 2024 - June 17, 2024).

The authors also attest that they did not submit substantially similar submissions to MICCAI 2024. Violation of any of these conditions will lead to automatic desk rejection. The goals of the dual submission policy are (i) to have exciting new work be published for the first time at MICCAI, and (ii) to avoid duplicating the effort of reviewers.

Our policy is based upon the following particular definition of "publication”, which for the purposes of the dual submission policy, is deemed to be a written work longer than three pages that was accepted for publication following peer review. In particular, this definition of publication does not depend upon whether such an accepted written work appears in formal proceedings or whether the organizers declare that such work "counts as a publication”. Note that such a definition does not consider university technical reports or pre-prints (e.g., arXiv), which are typically not peer reviewed. Likewise, disclosure of the work under review in an oral presentation is NOT considered a prior publication.

This definition of a publication does however include peer-reviewed workshop papers, even if they do not appear in the workshop proceedings, if their length is more than 3 pages including citations. Given this definition, any submission to MICCAI should not have substantial overlap with prior publications or other concurrent submissions. As a rule of thumb, the MICCAI submission should contain less than 20 percent of material from previous publications. An extended version of a paper submitted to MICCAI (with sufficiently new material) can be submitted to a journal any time after the MICCAI submission deadline (even before a final decision on the paper is sent to the authors). An author submitting an extended version of a MICCAI paper to a journal must ensure that the paper (a) satisfies all submission requirements of the intended journal, including those regarding possible overlap with conference publications, and (b) does not violate any copyright with Springer. Authors may also wish to notify the MICCAI Program Chairs of their journal submission.

Plagiarism: We will be actively checking for plagiarism. Plagiarism is a serious offence that consists of using wordings or results of someone else's publication without giving credit or providing appropriate referencing. Self-plagiarism, e.g., reuse of figures and sections of text from the authors' own previous publications, is also not permitted. Reviewers and Area Chairs can recognize such acts of plagiarism, and are asked to refer these to the MICCAI Organizing Committee who will investigate and in severe cases refer these cases to the MICCAI Society to determine further action.

iThenticate: By submitting a paper to MICCAI, the authors understand that papers are processed by iThenticate to ensure the originality of written work before publication.

Conflicts of interest: Conflicts of interest are inevitable in a community as networked as ours. To handle such conflicts, it is critical for the authors to provide a complete list of co-authors and an accurate list of domain conflicts at the time of submission. The author list cannot be modified after the submission. In rare occasions when there may be justifiable reasons to do this, any change in the author list must be justified in writing to the Program Chairs and be approved. In any circumstances it is unacceptable to include anyone as co-author who has been directly or indirectly involved with the manuscript at any stage of the decision process either as a reviewer, Area Chair or as part of the organizing committee; this includes any direct follow-on publications (e.g., MICCAI special journal issues).

The Use of Large Language Models (LLMs): The use of LLMs (such as ChatGPT) is allowed as a general-purpose writing assistance tool. Authors should understand that they take full responsibility for the contents of their papers, including content generated by LLMs that could be construed as plagiarism or scientific misconduct (e.g., fabrication of facts). LLMs are not eligible for authorship.

Publication: All accepted papers will be made available by Springer's Lecture Notes in Computer Science no earlier than two weeks prior to the conference. Authors wishing to submit a patent should understand that the paper's official public disclosure is two weeks before the conference or whenever the authors make it publicly available, whichever comes first. The conference considers papers confidential until publication two weeks prior to the conference, but notes that multiple organizations will have access during the review and production processes, so those seeking patents should discuss filing dates with their IP advisors. The conference assumes no liability for early disclosures.

MICCAI papers are subject to the standard Springer LNCS Copyright Agreement. Papers submitted to MICCAI must not be discussed with the media until they have been officially accepted for publication. Violations of the embargo will result in the paper being removed from the conference and proceedings.

5. Supplementary Material

Authors will be able to submit supplementary materials in the form of supporting images, tables, and proof of equations that do NOT represent additional results until the time of paper submission on March 7th, 2024. These materials must not exceed two pages and must NOT bear any identification markers. Supplementary material may include videos without any identification markers, proofs, more detailed analysis of experiments presented in the paper, or a concurrent submission to MICCAI or another conference. It may not include results on additional datasets, results obtained with an improved version of the method (e.g., following additional parameter tuning or training), or an updated or corrected version of the submission PDF. Captions should not exceed 100 words.

All supplementary material must be self-contained and zipped into a single file. Only the following formats are allowed: avi, mp4, pdf, wmv. We encourage authors to submit videos using an MP4 codec such as DivX contained in an AVI. Also, please submit a README text file with each video specifying the exact codec used and a URL where the codec can be downloaded.

While the reviewers will have access to such supplementary material, they are under no obligation to review it, and the paper itself must contain all necessary information and illustrations by itself.

If the paper is accepted, at the time of camera-ready version submission, authors may revise the supplementary material with format according to the guidelines above without the identification restrictions.

6. Rebuttal/Response Guide

The goal of the rebuttal/response process is

  • For early accepted papers: for the authors to (optionally) respond to misinterpretations or inaccuracies in the reviewer's findings. This may help inform the selection of orals and awards. The response will be published alongside the reviewer comments.
  • For borderline papers: to provide authors the opportunity to highlight possible misinterpretations or inaccuracies in the reviewer's findings, and inform the Area Chair's final recommendation. Rebuttals will be published along with the reviewer comments if the paper is accepted.

Rebuttals will be text only and of maximum 4000 characters. An effective rebuttal focuses only on major critiques. It is not helpful to try to address every minor point in the reviews. By prioritizing and focusing on the major concerns, and by grouping multiple reviewer comments that generally pertain to the same issue into a few major categories, you are demonstrating to the Area Chairs that you understand the high-level messages that were provided in the reviews.

Please summarize or paraphrase the criticism before you address it, and clarify to which comment(s) you are responding. While the room for rebuttal is limited, if properly utilized by condensing the response down to the essentials, this is an effective way to let the Area Chairs know that you understood the reviewer's concerns and have valid answers to the questions raised in the reviews, or to establish that certain reviewer comments were false or unsubstantiated.

An effective rebuttal addresses reviewers' criticisms by explaining where in the paper you had provided the requisite information, perhaps further clarifying it.

New/additional experimental results in the rebuttal are not allowed, and breaking this rule will lead to automatic rejection. The final decision is to be made based on the submitted manuscript. In all likelihood, there will not be sufficient room to add additional material to the paper, and the review timeline does not have a mechanism to verify that promised changes have been made. If accepted, authors are not allowed to make substantial changes to the submitted paper. The fundamental content of the paper, including experiments, data, analysis, should not be changed.

A good rebuttal is polite; being confrontational does not bring any added value to the paper. However, if you feel you have received a review that was not courteous, or made false or unsubstantiated arguments that you can succinctly refute, you should point this out.

7. Reproducible Research

MICCAI is committed to reproducible research. At MICCAI 2024, we strongly encourage authors to improve the reproducibility of their research along three directions: open data, open implementations, and appropriate evaluation design and reporting. Where possible, we invite authors to use open data or to make their data and/or code available for open access by other researchers. We encourage reviewers and Area Chairs to take reproducibility of the work into account when assessing a submission.

You are strongly encouraged to consider the following rules for scientific reproducibility.

  • For all models and algorithms, please include

    • A clear description of the mathematical setting, algorithm, and/or model.
    • A clear explanation of any assumptions.
    • A clear declaration of what software framework and version you used.
  • For all datasets used, please include:

    • The relevant statistics, such as number of examples.
    • Description of the study cohort.
    • For existing datasets, citations as well as descriptions if they are not publicly available.
    • For new data collected, a complete description of the data collection process, such as descriptions of the experimental setup, device(s) used, image acquisition parameters, subjects/objects involved, instructions to annotators, and methods for quality control.
    • A link to a downloadable version of the dataset (if public).
    • Whether ethics approval was necessary for the data.
  • For all code related to this work that you have made available or will release if this work is accepted, please include:

    • Specification of dependencies.
    • Training code.
    • Evaluation code.
    • (Pre-)trained model(s).
    • Dataset or link to the dataset needed to run the code.
    • README file including a table of results accompanied by precise command to run to produce those results.
  • For all reported experimental results, please include:

    • The range of hyper-parameters considered, method to select the best hyper-parameter configuration, and specification of all hyper-parameters used to generate results.
    • Information on sensitivity regarding parameter changes.
    • The exact number of training and evaluation runs.
    • Details on how baseline methods were implemented and tuned.
    • The details of train / validation / test splits.
    • A clear definition of the specific evaluation metrics and/or statistics used to report results.
    • A description of results with central tendency (e.g. mean) & variation (e.g. error bars).
    • An analysis of statistical significance of reported differences in performance between methods.
    • The average runtime for each result, or estimated energy cost.
    • A description of the memory footprint.
    • An analysis of situations in which the method failed.
    • A description of the computing infrastructure used (hardware and software).
    • Discussion of clinical significance.